Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1960 1
1966 1
1970 2
1971 3
1972 1
1973 2
1975 1
1977 1
1978 1
1985 1
1987 2
1988 5
1990 2
1991 3
1992 5
1993 1
1994 2
1995 3
1996 6
1997 8
1998 8
1999 6
2000 4
2001 3
2002 4
2003 4
2004 5
2005 17
2006 12
2007 3
2008 8
2009 15
2010 7
2011 9
2012 11
2013 8
2014 12
2015 23
2016 15
2017 5
2018 8
2019 3
2020 3
2021 4
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
Wykoff CC, Brown DM, Reed K, Berliner AJ, Gerstenblith AT, Breazna A, Abraham P, Fein JG, Chu KW, Clark WL, Leal S, Schmelter T, Hirshberg B, Yancopoulos GD, Vitti R; CANDELA Study Investigators. Wykoff CC, et al. JAMA Ophthalmol. 2023 Sep 1;141(9):834-842. doi: 10.1001/jamaophthalmol.2023.2421. JAMA Ophthalmol. 2023. PMID: 37535382
Preconditioning: gender effects.
Pitcher JM, Wang M, Tsai BM, Kher A, Turrentine MW, Brown JW, Meldrum DR. Pitcher JM, et al. J Surg Res. 2005 Dec;129(2):202-20. doi: 10.1016/j.jss.2005.04.015. Epub 2005 Jun 2. J Surg Res. 2005. PMID: 15936035 Review.
Sternal nonunion.
Coons DA, Pitcher JD, Braxton M, Bickley BT. Coons DA, et al. Among authors: pitcher jd. Orthopedics. 2002 Jan;25(1):89-91. doi: 10.3928/0147-7447-20020101-12. Orthopedics. 2002. PMID: 11811251 No abstract available.
G protein-coupled receptor kinases.
Pitcher JA, Freedman NJ, Lefkowitz RJ. Pitcher JA, et al. Annu Rev Biochem. 1998;67:653-92. doi: 10.1146/annurev.biochem.67.1.653. Annu Rev Biochem. 1998. PMID: 9759500 Review.
ErbB4 in the brain: Focus on high grade glioma.
Pitcher JL, Alexander N, Miranda PJ, Johns TG. Pitcher JL, et al. Front Oncol. 2022 Aug 31;12:983514. doi: 10.3389/fonc.2022.983514. eCollection 2022. Front Oncol. 2022. PMID: 36119496 Free PMC article. Review.
Cytokines in necrotizing enterocolitis.
Markel TA, Crisostomo PR, Wairiuko GM, Pitcher J, Tsai BM, Meldrum DR. Markel TA, et al. Among authors: pitcher j. Shock. 2006 Apr;25(4):329-37. doi: 10.1097/01.shk.0000192126.33823.87. Shock. 2006. PMID: 16670633 Review.
Granular-cell myoblastoma of the forearm.
Rooney RC, Pitcher JD. Rooney RC, et al. Among authors: pitcher jd. Orthopedics. 1998 Jan;21(1):89-90. doi: 10.3928/0147-7447-19980101-20. Orthopedics. 1998. PMID: 9474638 Review. No abstract available.
230 results